{"lastClose": 1.1699999570846558, "len": 487, "date": "2023-02-23", "alpha_1": -0.8983201860580907, "beta_1": 0.1646747098121357, "drawup_1": 0.7325581218050006, "natr_1": 31.27434118001091, "sup_1": -0.045299124137732176, "res_1": 0.2504273449410581, "bullPattern_1": ["SHORTLINE"], "bearPattern_1": [], "rsi_1": 64.4999929070498, "adx_1": 45.900833607421724, "drawdown_1": -0.9048152301462742, "stratHoldSharpe_1": -1.6558860742891575, "stratHoldAlpha_1": 249.82852625346086, "stratHoldDrawdown_1": -0.8276804057381537, "alpha_3mo": -0.037602246342829604, "beta_3mo": -0.30727644360285444, "drawup_3mo": 0.4117647223819081, "natr_3mo": 31.27434118001091, "sup_3mo": -0.03133896863854795, "res_3mo": 0.19373228778291884, "bullPattern_3mo": [], "bearPattern_3mo": ["SHORTLINE", "SPINNINGTOP"], "rsi_3mo": 63.362054015641576, "adx_3mo": 16.177161506776173, "drawdown_3mo": -0.4137931062832173, "stratHoldSharpe_3mo": -1.100228365266852, "stratHoldAlpha_3mo": 250.3536524371307, "stratHoldDrawdown_3mo": -0.3724137956548955, "Name": "LumiraDx Limited", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Market Cap": 290604594, "Country": "Cayman Islands", "Sector": "Health Care", "alpha%_1": 0.003822095209936312, "beta%_1": 0.053441456312930145, "drawup%_1": 0.6863987625940204, "natr%_1": 1.0, "drawdown%_1": 0.0034576389626854572, "stratHoldSharpe%_1": 0.004960488825061046, "stratHoldAlpha%_1": 9.748993166452454e-07, "stratHoldDrawdown%_1": 0.0037129533365838335, "alpha%_3mo": 0.2461695619400826, "beta%_3mo": 0.012958549607980138, "drawup%_3mo": 0.8143096282172635, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0007107360692735239, "stratHoldSharpe%_3mo": 0.11465686799195424, "stratHoldAlpha%_3mo": 0.04719518745612944, "stratHoldDrawdown%_3mo": 0.0008190529357355048}